| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Phosphatidylinositol 3-kinase regulatory subunit beta |
|---|
| Ligand | BDBM50434806 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | p110alpha (Alpha) PI3K Binding Assay |
|---|
| Ki | 53.0±n/a nM |
|---|
| Citation |  Braun, M; Hanan, E; Staben, ST; Heald, RA; MacLeod, C; Elliott, R Benzoxazepin oxazolidinone compounds and methods of use US Patent US10112932 Publication Date 10/30/2018 |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Phosphatidylinositol 3-kinase regulatory subunit beta |
|---|
| Name: | Phosphatidylinositol 3-kinase regulatory subunit beta |
|---|
| Synonyms: | P85B_HUMAN | PI3-kinase regulatory subunit beta | PI3-kinase subunit p85-beta | PI3K regulatory subunit beta | PIK3R2 | Phosphatidylinositol 3-kinase 85 kDa regulatory subunit beta | PtdIns-3-kinase regulatory subunit beta | PtdIns-3-kinase regulatory subunit p85-beta |
|---|
| Type: | Enzyme Subunit |
|---|
| Mol. Mass.: | 81542.75 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | O00459 |
|---|
| Residue: | 728 |
|---|
| Sequence: | MAGPEGFQYRALYPFRRERPEDLELLPGDVLVVSRAALQALGVAEGGERCPQSVGWMPGL
NERTRQRGDFPGTYVEFLGPVALARPGPRPRGPRPLPARPRDGAPEPGLTLPDLPEQFSP
PDVAPPLLVKLVEAIERTGLDSESHYRPELPAPRTDWSLSDVDQWDTAALADGIKSFLLA
LPAPLVTPEASAEARRALREAAGPVGPALEPPTLPLHRALTLRFLLQHLGRVASRAPALG
PAVRALGATFGPLLLRAPPPPSSPPPGGAPDGSEPSPDFPALLVEKLLQEHLEEQEVAPP
ALPPKPPKAKPASTVLANGGSPPSLQDAEWYWGDISREEVNEKLRDTPDGTFLVRDASSK
IQGEYTLTLRKGGNNKLIKVFHRDGHYGFSEPLTFCSVVDLINHYRHESLAQYNAKLDTR
LLYPVSKYQQDQIVKEDSVEAVGAQLKVYHQQYQDKSREYDQLYEEYTRTSQELQMKRTA
IEAFNETIKIFEEQGQTQEKCSKEYLERFRREGNEKEMQRILLNSERLKSRIAEIHESRT
KLEQQLRAQASDNREIDKRMNSLKPDLMQLRKIRDQYLVWLTQKGARQKKINEWLGIKNE
TEDQYALMEDEDDLPHHEERTWYVGKINRTQAEEMLSGKRDGTFLIRESSQRGCYACSVV
VDGDTKHCVIYRTATGFGFAEPYNLYGSLKELVLHYQHASLVQHNDALTVTLAHPVRAPG
PGPPPAAR
|
|
|
|---|
| BDBM50434806 |
|---|
| n/a |
|---|
| Name | BDBM50434806 |
|---|
| Synonyms: | 2-(4-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropanamide | CHEMBL2387080 | GDC 0032 | GDC-0032 | Roche RG7604 | Taselisib | US10851091, Compound taselisib | US8242104, Compound 196 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C24H28N8O2 |
|---|
| Mol. Mass. | 460.5315 |
|---|
| SMILES | CC(C)n1nc(C)nc1-c1cn2CCOc3cc(ccc3-c2n1)-c1cnn(c1)C(C)(C)C(N)=O |
|---|
| Structure | 
|
|---|
Search and Browse
